Estimation of Gestational Age by TCD

January 8, 2019 updated by: Mahmoud Alalfy, Aljazeera Hospital

Estimation of Gestational Age by Transcerebellar Diameter in Normal and Abnormal Pregnancy States

- Different parameters are used to estimate gestational age AC, HC , BPD and FL

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

-TCD is one of the parameters ,here we are testing its accuracy in calculating GA

Study Type

Observational

Enrollment (Anticipated)

700

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
      • Giza, Egypt
        • Recruiting
        • Algazeerah and Kasralainy hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 42 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

pregnant ladies with GA between 16 - 40 weeks

Description

Inclusion Criteria:

  • pregnant ladies with GA between 16 - 40 weeks

Exclusion Criteria:

  • pregnant ladies with GA less than 16 weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control group
Pregnant ladies with no medical disorders from 16 weeks till term
Diagnostic test: Ultrasonography
Ultrasonography with biometry and TCD measurement
case group
Pregnant ladies with medical disorders from 16 weeks till term
Diagnostic test: Ultrasonography
Ultrasonography with biometry and TCD measurement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of participants who will be exactly dated by TCD in comparison to LMP
Time Frame: within 4 months
The number of participants who will be exactly dated by TCD in comparison to LMP in weeks
within 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Aljazeera Hospital

Collaborators

National Research Centre, Egypt

Investigators

  • Principal Investigator: Mahmoud Alalfy, PhD, Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 16, 2018

Primary Completion (Anticipated)

May 1, 2019

Study Completion (Anticipated)

May 20, 2019

Study Registration Dates

First Submitted

November 5, 2018

First Submitted That Met QC Criteria

November 5, 2018

First Posted (Actual)

November 7, 2018

Study Record Updates

Last Update Posted (Actual)

January 9, 2019

Last Update Submitted That Met QC Criteria

January 8, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • cerebellum

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gestational Age and Weight Conditions

Clinical Trials on Ultrasonography

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe